Viyash Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VILOXAZINE HYDROCHLORIDE, with a corresponding US DMF Number 39715.
Remarkably, this DMF maintains an Active status since its submission on June 04, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 15, 2025, and payment made on April 04, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II